Hemogenyx15 Jun 2022 00:09
As for the analogy that HEMO have yet to leave the starting stalls, I’ll put that down to still sulking about being blocked on Twitter rather than a serious comment. To use your analogy this is pharma, it’s not a five furlong sprint it’s a long distance steeplechase with many obstacles to overcome. Firstly Hemogenyx have patent protection for all of their candidates. They now HAVE a partner to progress CBR, albeit unnamed. They HAVE received very positive feedback from the FDA on HEMO CAR-T and after one more external run will return to their own purpose built laboratory to begin engineering and manufacturing HEMO CAR-T with a view to IND application. In my opinion it’s certain to be approved and all the signs are it will be fast tracked through clinical trials. CDX is also progressing extremely well with an announcement of their progress expected later this month. I also believe Hemogenyx are fully funded for at least the next year, which is critical in this current bear market, rising interest rates and economic uncertainty. In my opinion this takes Hemogenyx through clinical proof of concept for HEMO CAR-T, which in all probability will mean major partner investment and eliminate the need for any further placement, ever. So by all means believe Hemogenyx are still stuck in the starting stalls, To me, Hemogenyx are very much in the race, they are nicely hidden tucked in mid field just waiting to make their move. Like others I’ve backed the jockey, Vlad, for many reasons but mainly because he told me too, he’s said he’s going to win the race and make us all a lot of money. I choose to believe him and am not at all concerned if nobody else does, each to their own in my view. He’ll make his move when he’s ready and certain of success and at that stage a lot of people will wish they’d backed him at this price because when it shortens Hemogenyx will look odds on for success.
Sign In
Follow the stocks
